Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel selective inhibitors of EGFR containing drug resistant mutation T790M

May 5, 2014

Proxalutamide, a novel androgen receptor antagonist for CRPC and prostate cancer

May 5, 2014

Oncodesign presents novel HER2-targeting DARPins

May 5, 2014

Favorable pharmacokinetics and pharmacodynamic activity of RPC-1063 in human volunteers

May 2, 2014

Lilly nociceptin receptor antagonist proves useful for various conditions

May 2, 2014

Roche and NCI present preclinical data for RG-7787

May 2, 2014

RP-5063 shows robust efficacy and safety in phase II REFRESH trial

May 2, 2014

NKTT-320 activates immunostimulatory functions of human iNKTs

May 2, 2014

Preclinical results presented for InvaplexAR, a Shigella vaccine

April 30, 2014

IMM-H007 reduces atherosclerotic plaque in mice and increases circulating HDL levels

April 30, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...